A Study of Remimazolam Tosilate for Sedation in the ICU

PHASE3CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

August 13, 2024

Study Completion Date

September 24, 2024

Conditions
Sedation in the ICU
Interventions
DRUG

Remimazolam Tosilate

Loading dose: 0.08mg/kg Maintenance dose: IV remimazolam tosilate, dose range 0-2.0mg/kg/h, increment or decrement of 0.1-0.2mg/kg/h

DRUG

Propofol Medium and Long Chain Fat Emulsion Injection

Loading dose: 0.3-0.5mg/kg Maintenance dose: IV Propofol Medium and Long Chain Fat Emulsion Injection, dose range 0.3-4.0mg/kg/h, increment or decrement of 0.3-0.6mg/kg/h

Trial Locations (1)

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06222294 - A Study of Remimazolam Tosilate for Sedation in the ICU | Biotech Hunter | Biotech Hunter